Lynne Powell Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lynne Powell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lynne Powell. Lynne Powell is Senior VP - CCO in BIOCRYST PHARMACEUTICALS INC ($BCRX).
Lynne Powell in BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Lynne Powell: Senior VP - CCO
Holdings: 6,000 shares
Current Value: $34,020
Latest Transaction: Jan 29 2019
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Lynne Powell in BIOCRYST PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 79,427 | |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 4,000 | 12,880 | 81,427 | |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 6,000 | 19,320 | 85,427 | |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.91 | 2,000 | 19,820 | 0 | 2 K to 0 (-100.00 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.88 | 4,000 | 39,520 | 0 | 4 K to 0 (-100.00 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 4,000 | 12,880 | 4,000 | 0 to 4 K |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.60 | 6,000 | 57,600 | 0 | 6 K to 0 (-100.00 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 6,000 | 19,320 | 6,000 | 0 to 6 K |
| Jan 23 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 91,427 | |
| Jan 23 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.40 | 2,000 | 18,800 | 0 | 2 K to 0 (-100.00 %) |
| Jan 23 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Jan 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 3,046 | 9,808 | 93,427 | |
| Jan 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.27 | 3,046 | 28,236 | 0 | 3 K to 0 (-100.00 %) |
| Jan 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 3,046 | 9,808 | 3,046 | 0 to 3 K |
| Jan 16 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 954 | 3,072 | 96,473 | |
| Jan 16 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.20 | 954 | 8,777 | 0 | 954 to 0 (-100.00 %) |
| Jan 16 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 954 | 3,072 | 954 | 0 to 954 |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | A | 7.06 | 190,000 | 1,341,400 | 190,000 | |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 97,427 | |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 99,427 | |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.11 | 2,000 | 18,220 | 0 | 2 K to 0 (-100.00 %) |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.01 | 2,000 | 18,020 | 0 | 2 K to 0 (-100.00 %) |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 12,000 | 38,640 | 101,427 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.01 | 2,455 | 22,120 | 0 | 2.5 K to 0 (-100.00 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.06 | 12,000 | 108,720 | 2,455 | 14.5 K to 2.5 K (-83.02 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 12,000 | 38,640 | 14,455 | 2.5 K to 14.5 K (+488.80 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 9,127 | 29,389 | 113,427 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 9,127 | 29,389 | 113,427 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 193 | 621 | 122,554 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 193 | 621 | 122,554 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.61 | 6,150 | 52,952 | 2,455 | 8.6 K to 2.5 K (-71.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.61 | 6,150 | 52,952 | 2,455 | 8.6 K to 2.5 K (-71.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.52 | 9,127 | 77,762 | 8,605 | 17.7 K to 8.6 K (-51.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.52 | 9,127 | 77,762 | 8,605 | 17.7 K to 8.6 K (-51.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 9,127 | 29,389 | 17,732 | 8.6 K to 17.7 K (+106.07 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 9,127 | 29,389 | 17,732 | 8.6 K to 17.7 K (+106.07 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.30 | 193 | 1,602 | 8,605 | 8.8 K to 8.6 K (-2.19 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.30 | 193 | 1,602 | 8,605 | 8.8 K to 8.6 K (-2.19 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 193 | 621 | 8,798 | 8.6 K to 8.8 K (+2.24 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 193 | 621 | 8,798 | 8.6 K to 8.8 K (+2.24 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 5,280 | 17,002 | 122,747 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 300 | 966 | 128,027 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.15 | 5,280 | 43,032 | 8,605 | 13.9 K to 8.6 K (-38.03 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 5,280 | 17,002 | 13,885 | 8.6 K to 13.9 K (+61.36 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 300 | 2,400 | 8,605 | 8.9 K to 8.6 K (-3.37 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 300 | 966 | 8,905 | 8.6 K to 8.9 K (+3.49 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 100 | 322 | 128,327 | |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 100 | 800 | 8,605 | 8.7 K to 8.6 K (-1.15 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 100 | 322 | 8,705 | 8.6 K to 8.7 K (+1.16 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 1,000 | 3,220 | 128,427 | |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 1,000 | 8,000 | 8,605 | 9.6 K to 8.6 K (-10.41 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 1,000 | 3,220 | 9,605 | 8.6 K to 9.6 K (+11.62 %) |
| Nov 05 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 7.51 | 1,544 | 11,595 | 8,605 | 10.1 K to 8.6 K (-15.21 %) |
| Oct 23 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 7.50 | 100 | 750 | 10,149 | 10.2 K to 10.1 K (-0.98 %) |
| Dec 22 2017 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | A | 5.04 | 80,000 | 403,200 | 80,000 | |
| Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | A | 11.33 | 30,000 | 339,900 | 30,000 | |
| Mar 01 2017 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | A | 5.51 | 150,000 | 826,500 | 150,000 | |
| May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | A | 3.22 | 129,427 | 416,755 | 129,427 | |
| Jan 27 2016 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Payment of Exercise | F | 7.29 | 3,850 | 28,067 | 8,605 | 12.5 K to 8.6 K (-30.91 %) |
| Dec 31 2015 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | A | 10.82 | 62,573 | 677,040 | 62,573 | |
| Jan 28 2015 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | A | 11.33 | 190,000 | 2,152,700 | 190,000 | |
| Jan 28 2015 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1